About
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.
- Website
- Headquarters
- Industries
- Employees51-200
- Social
Photos
Add photos to showcase Immunovant’s culture
Values
Add Immunovant’s values
Insider experiences
Share your experience of working at Immunovant
Org chart
View org chartPeter Salzmann
Chief Executive Officer
Collapse
Renee Barnett
Chief Financial Officer
William Macias
Chief Medical Officer
Julia G. Butchko
Chief Development & Technology Officer
Mark Levine
Chief Legal Officer & Corporate Secretary
Ronald Bates
VP, CMC Process Development
Yan Zheng
VP of Biostatistics & Programming
Jody Roth
VP of Global Regulatory Affairs
Lauren Schrier
VP, Marketing
Lesa Valentine
VP, Quality
Joanne Sloan Lancaster
VP, Program & Alliance Management
Teams
View all (0)Add your teams to show how people work together at Immunovant
Jobs
View all (0)Add jobs to your org chart to show candidates who they’ll work with
Wires
View all (0)Publish company announcements to get more exposure
Similar organizations
Explore 140.000+ org charts
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.